Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Sell
18,518
-6,255
-25% -$4.16M 2.72% 8
2026
Q1
$13.5M Sell
24,773
-22,322
-47% -$9.1M 3.04% 5
2025
Q4
$14.8M Buy
47,095
+1,090
+2% +$346K 1.93% 19
2025
Q3
$12.4M Buy
46,005
+1,308
+3% +$300K 1.65% 30
2025
Q2
$9.85M Buy
44,697
+11,354
+34% +$2.05M 1.38% 35
2025
Q1
$4.37M Sell
33,343
-9,229
-22% -$1.29M 0.69% 45
2024
Q4
$5.83M Buy
42,572
+13,516
+47% +$1.86M 0.77% 35
2024
Q3
$2.95M Buy
29,056
+2
+0% +$158 0.68% 40
2024
Q2
$2.13M Buy
+29,054
New +$1.9M 0.53% 68

Other funds holding AGX

Abacus FCF Advisors's AGX Position: Q2 2026 in Review

Abacus FCF Advisors reduced its Argan (AGX) stake by 25% in Q2 2026, selling an estimated $4.16M and leaving 18,518 shares worth $14.8M. The position accounts for 2.72% of the portfolio, ranked #8.

Abacus FCF Advisors first reported a position in AGX in Q2 2024 and has held it in 9 quarters since. 563 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Abacus FCF Advisors held 18,518 shares of Argan worth $14.8M as of Q2 2026.
  • Abacus FCF Advisors sold 6,255 Argan shares in Q2 2026, an estimated $4.16M.
  • Argan made up 2.72% of Abacus FCF Advisors's portfolio in Q2 2026, its #8 holding.
  • Abacus FCF Advisors first reported a position in Argan in Q2 2024 and has held it in 9 quarters since.
  • 563 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Abacus FCF Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.